BioNTech SE (BNTX)
NASDAQ
$98.52−$0.7400 (−0.75%) on the dayAs of the close; data may be delayed.
BNTX price, last 12 months
Key stats
- Previous close
- $99.26
- Open
- $99.51
- Day range
- $97.73 – $100.02
- 52-week range
- $79.52 – $124.00
- Volume
- 580K
- Avg volume (20 days)
- 999.8K
- Market cap
- $24.7B
Performance
1W+2.6%
1M−12.5%
3M+8.0%
6M+12.7%
YTD+3.5%
1Y−1.2%
vs S&P 500, 1Y−18.0 pts
Technicals and fundamentals
About BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
- Listed on
- NASDAQ
- Market cap
- $24.7B